The Biological Safety Testing Products and Services Market was valued at $4.42 billion in 2023 and is expected to surge to $10.51 billion by 2032, growing at a CAGR of 10.10% over the forecast period of 2024-2032. The increasing demand for biologics, stringent regulatory frameworks, and heightened focus on ensuring drug and vaccine safety are driving market expansion.Key Market DriversThe rapid ..